Recombinant Human LAIR2 Protein , His

LAIR2 (Leukocyte Associated Immunoglobulin-like Receptor 2) is a receptor that belongs to the immunoglobulin superfamily, primarily known for its role in modulating immune responses. It is expressed on various immune cells and is involved in the regulation of inflammation and immune tolerance. Research into LAIR2 has gained significance due to its potential implications in various diseases, including autoimmune disorders and cancer. LAIR2 acts as a negative regulator of immune activation, which can be beneficial in preventing tissue damage during inflammatory responses but may also promote tumor immune evasion. The study of LAIR2 recombinantly has gained traction to better understand its structural, functional, and therapeutic potential. Recombinant LAIR2 proteins can be engineered to investigate their binding affinities, intracellular signaling pathways, and interactions with ligands, thus providing insights into their role within the immune system. This research could pave the way for new immunotherapeutic strategies aimed at enhancing anti-tumor immunity or modulating autoimmune conditions. By elucidating the mechanisms of LAIR2 action, scientists hope to improve the design of therapeutic agents that can either activate or inhibit LAIR2 function, ultimately contributing to the development of novel treatments for a variety of immune-related diseases.